Genetic background of Lewis negative blood group phenotype and its association with atherosclerotic disease in the NHLBI Family Heart Study

Journal of Internal Medicine

Volumn 247, Issue 6, 2000, Pages 689-698

  Salomaa, Veikko ^a   Pankow, J ^b   Heiss, G ^b   Cakir, B ^b   Eckfeldt, J H ^d   Ellison, R C ^e   Myers, R H ^e   Hiller, K M ^c   Brantley, K R ^c   Morris, T L ^c   Weston, B W ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b USA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

(1, 3 1, 4) fucosyltransferase; Coronary heart disease; Lewis gene

Indexed keywords

C REACTIVE PROTEIN; FUCOSYLTRANSFERASE;

ARTICLE; ATHEROSCLEROSIS; BLOOD GROUP LEWIS SYSTEM; CARDIOVASCULAR RISK; CAUCASIAN; FAMILY STUDY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL;

ARTERIOSCLEROSIS; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DNA PRIMERS; FUCOSYLTRANSFERASES; GENE AMPLIFICATION; HUMANS; LEWIS BLOOD-GROUP SYSTEM; MUTATION; ODDS RATIO; PHENOTYPE;

EID: 0033948565     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2000.00682.x     Document Type: Article

References (34)

1. 1 Hein HO, Sørensen H, Suadicani P, Gyntelberg F. The Lewis blood group - a new genetic marker of ischaemic heart disease. J Intern Med 1992; 232: 481-7.
2. 2 Ellison RC, Zhang Y, Myers RH, Swanson JL, Higgins M, Eckfeldt J. Lewis blood group phenotype as an independent risk factor for coronary heart disease (The NHLBI Family Heart Study). Am J Cardiol 1999; 83: 345-8.
3. 3 Watkins WM, Biosynthesis. Molecular basis of antigenic specificity in the ABO, H and Lewis blood group systems. In: Montreuil J, Schachter H, Vligenhart JFG, eds. Glycoproteins, Chapter 5. Amsterdam, the Netherlands: Elsevier, 1995: 313-90.
4. 4 Ruiz B, Correa P, Fontham ET, Rood JC, Malcom GT, Torrado J, et al. Ascorbic acid, Helicobacter pylori and Lewis phenotype among blacks and whites in New Orleans. Cancer Lett 1994; 83: 323-9.
5. 5 Mourant AE, Kopec AC, Damaniewska-Sobczak K. The Distribution of the Human Blood Groups and Other Polymorphisms London, UK: Oxford University Press, 1976.
6. 6 Clausen JO, Hein HO, Suadicani P, Winther K, Gyntelberg F, Pedersen O. Lewis phenotypes and the insulin resistance syndrome in young healthy white men and women. Am J Hypertens 1995; 8: 1060-6.
7. 7 Green D, Jarret O, Ruth KJ, Folsom AR, Liu K. Relationship among Lewis phenotype, clotting factors, and other cardiovascular risk factors in young adults. J. Lab Clin Med 1995; 125: 334-9.
8. 8 Petit JM, Morvan Y, Viviani V, Vaillant G, Matejka G, Rohmer JF, et al. Insulin resistance syndrome and Lewis phenotype in healthy men and women. Horm Metab Res 1997; 29: 193-5.
9. 9 Mollicone R, Cailleau A, Oriol R. Molecular Genetic of H, Se, Lewis and other fucosyltransferase genes. TCB 1995; 4: 235-42.
10. 10 Greenwall P. Blood group antigens: molecules seeking a function? Glycoconj J 1997; 14: 159-73.
11. 11 Henry S, Oriol R, Samuelsson B, lewis histo-blood group system, associated secretory phenotypes. Vox Sang 1995; 69: 166-82.
12. 12 Lowe JB. Selectin ligands, leukocyte trafficking, and fucosyltransferase genes. Kidney Int 1997; 51: 1418-26.
13. 13 Revelle BM, Scott D, Kogan TP, Zheng J, Beck PJ. Structure-function analysis of P-selectin-sialyl LewisX binding interactions. Mutagenic alteration of ligand binding specificity. J Biol Chem 1996; 271: 4289-97.
14. 14 von .14. Adrian UH, Chambers JD, Berg EL, Michie SA, Brown DA, Karolak D, et al. L-selectin mediates neutrophil rolling in inflamed venules through sialyl LewisX-dependent and -independent recognition pathways. Blood 1993; 82: 182-91.
15. 15 Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-26.
16. 16 Kukowska-Latallo JF, Larsen RD, Nair RP, Lowe JB. A cloned human c DNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group α(1,3/ 1,4) fucosyltransferase. Genes Dev 1990; 4:1288-303.
17. 17 Costache M, Cailleau A, Fernandez-Mateos P, Oriol R, Mollicone R. Advances in molecular genetics of α-2-and α3/4-fucosyltransferases. Transfus Clin Biol 1997; 4: 367-82.
18. 18 Mollicone R, Reguigne I, Kelly R, Fletcher A, Watt J, Chatfield S, et al. Molecular Basis for α(1,3/1,4) fucosyltransferase gene deficiency (FUT3) found in Lewis-negative Indonesian Pedigrees. J Biol Chem 1994; 269: 20 987-94.
19. 19 Elmgren A, Börjeson C, Svensson L, Rydberg L, Larson G. DNA sequencing and screening for point mutations in the human Lewis (FUT3) gene enables molecular genotyping of the human Lewis blood group system. Vox Sang 1996; 70: 97-103.
20. 20 Nishihara S, Hiraga T, Ikehara Y, Iwasaki H, Kudo T, Yazawa S, Morozumi K, Suda Y, Narimatsu H. Molecular behavior of mutant Lewis enzymes in vivo. Glycobiol 1999; 9: 373-82.
21. 21 Elmgren A, Mollicone R, Costache M, Börjeson C, Oriol R, Harrington J, Larson G. Significance of individual point mutations, T202C and C314T, in the human Lewis (FUT3) gene for expression of Lewis antigens by the human α(1,3/ 1,4) fucosyltransferase, Fuc-TIII. J Biol Chem 1997; 272:21 994-8.
22. 22 Nishihara S, Narimatsu H, Iwasaki H, Yazawa S, Akamatsu S, Ando T, et al. Molecular genetic analysis of the human Lewis histo-blood group system. J Biol Chem 1994; 269: 29 271-8.
23. 23 Liu Y, Koda Y, Soejima M, Uchida N, Kimura H. PCR analysis of Lewis-negative gene mutations and the distribution of Lewis alleles in a Japanese population. J Forensic Sci 1996; 41: 1018-21.
24. 24 Liu YH, Koda Y, Soejima M, Pang H, Wang B, Kimura H. Lewis (FUT3) genotypes in two different Chinese populations. J Forensic Sci 1999; 44: 82-6.
25. 25 Pang H, Liu Y, Koda Y, Soejima M, Jia J, Schaphoff T, et al. Five novel missense mutations of the Lewis gene (FUT3) in African (Xhosa) and Caucasian populations in South Africa. Hum Genet 1998; 102: 675-80.
26. 26 Higgins M, Province M, Heiss G, Eckfeldt J, Ellison RC, Folsom AR, et al. NHLBI Family Heart Study: objectives and design. Am J Epidemiol 1996; 143: 1219-28.
27. 27 Bond MG, Barnes RW, Riley WA, Wilmoth SK, Chambless LE, Howard G, Owens B. High-resolution B-mode ultrasound scanning methods in the atherosclerosis risk in communities study (ARIC). J Neuroimag 1991; 1: 68-73.
28. 28 Riley WA, Barnes RW, Bond MG, Evens G, Chambless LE, Heiss G. High-resolution B-mode ultrasound reading methods in the atherosclerosis risk in communities (ARIC) cohort. J Neuroimag 1991; 1: 168-72.
29. 29 Macy EM, Hayes TE, Tracy RP. Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. Clin Chem 1997; 43: 52-8.
30. 30 Dunsford I, Boley CC. Techniques in Blood Grouping. Edinburgh, UK: J & J Gray, Oliver and Boyd, 1995.
31. 31 Cameron HS, Szczepaniak D, Weston BW. Expression of Human Chromosome 19p α(1,3/1,4) fucosyltransferase genes in normal tissues. J Biol Chem 1995; 270: 20 112-22.
32. 32 Schneider S, Kueffer J-M, Roessli D, Excoffier L. Arlequin, Version 1.1: a Software for Population Genetic Data Analysis. University of Geneva, Switzerland: Genetics and Biometry Laboratory, 1997.
33. 33 SAS Institute Inc. SAS/Stat Users Guide, Version 6, 4th edn, v. 1 and 2. Gary, NC: SAS Institute, Inc, 1990.
34. 34 Stengård JH, Weiss KM, Sing CF. An ecological study of association between coronary heart disease mortality rates in men and the relative frequencies of common allelic variations in the gene coding for apolipoprotein E. Hum Genet 1998; 103: 234-11.